Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,775 | -9,165 | -7,356 | -2,626 | -9,888 |
| Depreciation Amortization | 64 | 46 | 29 | 12 | N/A |
| Accounts payable and accrued liabilities | 580 | -244 | 196 | 266 | 177 |
| Other Working Capital | 569 | -950 | -172 | -129 | 132 |
| Other Operating Activity | 2,502 | 2,843 | 2,068 | -2 | 1,753 |
| Operating Cash Flow | $-9,060 | $-7,470 | $-5,235 | $-2,479 | $-7,826 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 2,329 |
| Other Financing Activity | -71 | -71 | -71 | -71 | 18 |
| Financing Cash Flow | $-71 | $-71 | $-71 | $-71 | $2,347 |
| Beginning Cash Position | 22,781 | 22,781 | 22,781 | 22,781 | 28,260 |
| End Cash Position | 13,650 | 15,240 | 17,475 | 20,231 | 22,781 |
| Net Cash Flow | $-9,131 | $-7,541 | $-5,306 | $-2,550 | $-5,479 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,060 | -7,470 | -5,235 | -2,479 | -7,826 |
| Free Cash Flow | -9,060 | -7,470 | -5,235 | -2,479 | -7,826 |